Insiders trading at Allogene Therapeutics Inc

Over the last 5 years, insiders at Allogene Therapeutics Inc have traded over $137,425,678 worth of Allogene Therapeutics Inc stock and bought 1,166,977 units worth $24,332,453 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Inc Pfizer, and Arie Belldegrun. On average, Allogene Therapeutics Inc executives and independent directors trade stock every 26 days with the average trade being worth of $405,076. The most recent stock trade was executed by Deborah M. Messemer on 18 December 2023, trading 18,640 units of ALLO stock currently worth $50,328.